Indirect Calorimetry Devices for Mechanically Ventilated Children

Overseen By Nilesh M Mehta, MD

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: Boston Children's Hospital

Disqualifiers: Hemodynamic instability, ECMO, end-of-life care, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

40 Participants Needed

Trial Summary

What is the purpose of this trial?

The overarching aim of this proposal is to examine the feasibility of the Q-NRG+ indirect calorimetry device and its agreement with (Vmax) Encore indirect calorimetry device in mechanically ventilated children. The overall hypothesis of this study is that the Q-NRG+ will provide minute-to-minute oxygen consumption (VO2) and carbon dioxide production (CO2) measurements that are in agreement with those obtained by the standard indirect calorimetry device currently used at our institution (Vmax Encore).

Research Team

Nilesh M Mehta, MD

Principal Investigator

Boston Children's Hospital

Eligibility Criteria

This trial is for children over 10 years old and weighing more than 10kg who are on mechanical ventilation with specific settings. They must not have severe lung leaks, be unstable in their blood pressure, or be receiving end-of-life care.

Inclusion Criteria

ETT leak < 10%

My doctor plans to measure my metabolism and believes research is safe for me.

I am older than 10 years and weigh more than 10kg.

Exclusion Criteria

I currently have a chest tube due to an air leak.

My primary doctor has not approved me joining the trial.

I do not have severe low blood pressure or need multiple medications to increase my blood pressure.

Treatment Details

Interventions

• Q-NRG+ Indirect Calorimetry Device
• V(max) Encore Indirect Calorimetry Device

Trial Overview The study is testing the Q-NRG+ device against the standard V(max) Encore device to measure oxygen consumption and carbon dioxide production in ventilated children to see if they agree on results.

Participant Groups

Group I: V(max) Encore Indirect Calorimetry Device Experimental Treatment 1 Intervention

V(max) Encore device, currently institution's standard device, will be compared to Q-NRG+ device in each enrolled patient in subsequent, alternating fashion.

Group II: Q-NRG+ Indirect Calorimetry Device Experimental Treatment 1 Intervention

Q-NRG+ device will be compared to current V(max) device in each enrolled patient in subsequent, alternating fashion.

Who Is Running the Clinical Trial?

Boston Children's Hospital

Lead Sponsor

Trials

801

Recruited

5,584,000+